Bile acids reduce SR-BI expression in hepatocytes by a pathway involving FXR/RXR, SHP, and LRH-1

Hepatic SR-BI mediates uptake of circulating cholesterol into liver hepatocytes where a part of the cholesterol is metabolised to bile acids. In the hepatocytes, bile acids reduce their own synthesis by a negative feedback loop to prevent toxic high levels of bile acids. Bile acid-activated FXR/RXR...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 336; no. 4; pp. 1096 - 1105
Main Authors Malerød, Lene, Sporstøl, Marita, Juvet, Lene K., Mousavi, Seyed Ali, Gjøen, Tor, Berg, Trond, Roos, Norbert, Eskild, Winnie
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 04.11.2005
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Hepatic SR-BI mediates uptake of circulating cholesterol into liver hepatocytes where a part of the cholesterol is metabolised to bile acids. In the hepatocytes, bile acids reduce their own synthesis by a negative feedback loop to prevent toxic high levels of bile acids. Bile acid-activated FXR/RXR represses expression of CYP7A1, the rate-limiting enzyme during bile acid synthesis, by inducing the expression of SHP, which inhibits LXR/RXR and LRH-1-transactivation of CYP7A1. The present paper presents data indicating that CDCA suppresses SR-BI expression by the same pathway. As previously reported, LRH-1 induces SR-BI promoter activity. Here we show that CDCA or over-expression of SHP inhibit this transactivation. No FXR-response element was identified in the bile acid-responsive region of the SR-BI promoter (−1200 bp/−937 bp). However, a binding site for LRH-1 was characterised and shown to specifically bind LRH-1. The present study shows that also the SR-BI-mediated supply of cholesterol, the substrate for bile acid synthesis, is feedback regulated by bile acids.
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2005.08.237